Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding.
about
SSRIs increase risk of blood transfusion in patients admitted for hip surgery.Selective serotonin reuptake inhibitors and gastrointestinal bleeding: a case-control study.Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients.Observational study of upper gastrointestinal tract bleeding events in patients taking duloxetine and nonsteroidal anti-inflammatory drugs: a case-control analysis.Upper gastrointestinal bleeding in a patient receiving selective serotonin reuptake inhibitor.Bleeding incidence with concomitant use of antidepressants and warfarin.Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants.Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based settingThe risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports.Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.The relationship among proton pump inhibitors, bone disease and fracture.Clinically significant drug interactions with newer antidepressants.Hemarthrosis in a patient on warfarin receiving ceftaroline: a case report and brief review of cephalosporin interactions with warfarin.Metabolic and toxicological considerations for obsessive-compulsive disorder drug therapy.Depressive syndromes in neurological disorders.Defining a reference set to support methodological research in drug safety.Extended-release quetiapine fumarate in the treatment of patients with major depressive disorder: adjunct therapy.Serotonergic antidepressants and perioperative bleeding risk: a systematic review.Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis.Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients.Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial.Serotonin reuptake inhibitors and post-gastrostomy bleeding: reevaluating the link.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppressionEditorial: venlafaxine for functional chest pain: hope or hype?Helicobacter pylori and risk of upper gastrointestinal bleeding among users of selective serotonin reuptake inhibitors.Use of serotonergic drugs and the risk of bleeding.Suppressive effect of citalopram on plasma concentrations of thromboxane B2.Correlation of antidepressive agents and the mortality of end-stage renal disease.Sertraline-induced periorbital purpura: a case report.Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review.The Effect of Sibutramine, a Serotonin-Norepinephrine Reuptake Inhibitor, on Platelets and Fibrin Networks of Male Sprague-Dawley Rats: A Descriptive Study
P2860
Q33644329-0405650A-07C4-491B-8885-3F0C717CB6C4Q33916845-CAADC13F-ABAF-4598-AD6A-3428432DE4E7Q34182611-FE57DBE8-C7E7-4FEF-96A2-4C8D9482D761Q34462222-F6438029-EDF2-4D3B-B8F8-BDD2D8AA34CEQ35018302-0B438D11-E50C-4B1D-974D-6A4FD5BB2EA8Q35539353-52FFF645-819E-47F2-8EBB-4B5D71E30008Q35899461-7F69AAEB-506B-430D-A820-9F1675B39AE0Q36733540-E54620D1-B196-4789-98C5-72D4A20786DEQ37360532-CC53B0F5-8A11-4AED-9D6B-A9FCF263D53EQ37524726-D5752C48-988A-490D-A1C1-A3FF94945F67Q37877712-26806557-C744-4C35-A98D-CD59D66A59C0Q37968621-4E545117-6BBB-4D07-93C1-519FE02F2E12Q38024092-A5F2A74E-F14A-41F9-B10E-05651E53318FQ38092129-016D14DD-FF3E-48B1-8823-86677B91EDD2Q38146845-16958870-8E97-4489-A5D1-1379DD32AAFFQ38156066-66F6A047-1B7E-40DB-94C1-84A9ACD4C502Q38157027-DFB43844-5143-4DEC-8BA2-09A0C8A7AA9DQ38203347-2114DB57-029A-484F-865A-0AB8C2110AC7Q38207875-A5F29D30-98F3-465B-A466-1653F54A546DQ38402064-83054F00-CB13-4099-9A54-0D16D60F5940Q38476909-DCDA1185-1D8F-4EA5-A7D6-82279D429AAEQ39288869-175BC53D-2AEC-46E0-8BD5-E5FC67CC0EC8Q42127953-C98E9EF3-8792-441C-9611-E753863ED7C3Q42371575-2C5B1310-8F33-4EAF-A3AA-EC97674365E1Q42698067-BD84DD69-18A8-421B-8CDD-5A3E93039EECQ43821335-AE701529-4388-412D-AA26-15DD45995C2AQ44648860-BAB11D23-A491-4448-931A-230479C9D53DQ48077623-6310423B-7CB5-4588-BAD9-B7B4E7940152Q48750587-C9B7D2F8-5208-4AE1-BD4D-28C031FE4278Q51025625-AB7B6189-8A0C-4BD5-B23C-751F4533ADA8Q55054440-1899FCDA-441C-49A6-B9DB-2C482A56EAA2Q58068053-31B99E7F-3693-43D4-B465-04A8A9044B71
P2860
Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Selective serotonin reuptake i ...... per gastrointestinal bleeding.
@en
Selective serotonin reuptake i ...... per gastrointestinal bleeding.
@nl
type
label
Selective serotonin reuptake i ...... per gastrointestinal bleeding.
@en
Selective serotonin reuptake i ...... per gastrointestinal bleeding.
@nl
prefLabel
Selective serotonin reuptake i ...... per gastrointestinal bleeding.
@en
Selective serotonin reuptake i ...... per gastrointestinal bleeding.
@nl
P2093
P2860
P356
P1476
Selective serotonin reuptake i ...... per gastrointestinal bleeding.
@en
P2093
Colleen J Metge
James M Bolton
Jitender Sareen
Laura E Targownik
Stella Leung
P2860
P304
P356
10.1038/AJG.2009.128
P407
P577
2009-04-28T00:00:00Z